News SofWave Medical Ltd.

Equities

SOFW

IL0011754392

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 13:49:55 19/05/2024 BST			5-day change	1st Jan Change
1,717 ^ILa	-1.77%		-4.82%	+25.15%

05-09	SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-06	SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights	05-09	AQ
SofWave Medical : Presentation- Q1 2024 Summary-May 2024	05-09	PU
SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	03-28	AQ
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	03-06	AQ
SofWave Medical : Presentation- Investor Meeting-March 2024	03-06	PU
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	03-04	AQ
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	02-28	AQ
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	02-12	AQ
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer	02-12	CI
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	01-03	AQ
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	01-03	CI
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	12-26	AQ
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	12-26	CI
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	11-20	AQ
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	11-08	AQ
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars	30/08/23	AQ
Sofwave Medical Announces FDA Clearance of SUPERB? Technology For Treatment of Acne Scars	30/08/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SofWave Medical Ltd.

Equities

SOFW

IL0011754392

Summary

Filters